Alkem Laboratories Ltd Announces Resignation of Chief Executive Officer Dr. Vikas Gupta
Alkem Laboratories Ltd announced the resignation of Dr. Vikas Gupta from the position of Chief Executive Officer and Key Managerial Personnel. The resignation, effective April 24, 2026, was tendered by Dr. Gupta to pursue new professional opportunities.According to the company, Dr. Vikas Gupta will continue in his role until June 30, 2026, to ensure a smooth transition of responsibilities for Alkem Laboratories Ltd.
The company stated that Dr. Gupta expressed deep gratitude for the tenure, noting that the leadership efforts focused on strengthening the market position and advancing the research and development (R&D) pipeline.
The key details regarding the change in management personnel are as follows:
| Particulars | Details |
|---|---|
| Individual Resigning | Dr. Vikas Gupta (CEO & Key Managerial Personnel) |
| Reason for Departure | To pursue new professional opportunities |
| Last Working Day | June 30, 2026 |
During his remaining tenure, Dr. Gupta remains fully committed to assisting the management. He has assured that he will ensure a seamless handover of all ongoing strategic initiatives and leadership responsibilities through the transition period.
Alkem Laboratories Ltd. confirmed that the details concerning the change in key managerial personnel were reported on April 24, 2026.
ALKEM Stock Price Movement
Shares of Alkem Laboratories Limited are slipping 1.40% in live trading, currently trading at ₹5443 as of 2:47 PM. The stock registered a volume of 47,319 shares, contributing to the intraday downward pressure.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.